Jan F Meilof
Overview
Explore the profile of Jan F Meilof including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Weijden C, Ahmed A, van der Hoorn A, Zhu J, Wu C, Wang Y, et al.
J Nucl Med
. 2024 Dec;
66(1):136-141.
PMID: 39638431
Multiple sclerosis (MS) is a neurodegenerative disease characterized by demyelinated lesions in the brain and spinal cord. A few clinical studies using PET to image myelin in the brain have...
2.
van der Weijden C, Pitombeira M, Peretti D, Campanholo K, Kolinger G, Rimkus C, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274448
: Multiple sclerosis (MS) has two main phenotypes: relapse-remitting MS (RRMS) and progressive MS (PMS), distinguished by disability profiles and treatment response. Differentiating them using conventional MRI is challenging. :...
3.
Tan I, Modderman R, Stachurska A, Almeida R, de Vries R, Heersema D, et al.
Brain Commun
. 2024 Jul;
6(4):fcae209.
PMID: 38978729
Multiple sclerosis is a chronic demyelinating disease of the central nervous system. There is a need for new circulating biomarkers for multiple sclerosis, in particular, markers that differentiate multiple sclerosis...
4.
Reinhardt A, Rakers S, Heersema D, Beenakker E, Meilof J, Timmerman M, et al.
BMC Neurol
. 2024 Jun;
24(1):224.
PMID: 38943063
Background: Neuropsychological symptoms in the Cognitive, Energetic, Behavioural, and Affective (CEBA) domains are common in people with multiple sclerosis (PwMS) and can negatively affect societal participation. The current study aims...
5.
van der Weijden C, Biondetti E, Gutmann I, Dijkstra H, McKerchar R, Faria D, et al.
Brain
. 2022 Nov;
146(4):1243-1266.
PMID: 36408715
Myelin is the protective sheath wrapped around axons, consisting of a phospholipid bilayer with water between the wraps. The measurement of damage to the myelin sheaths, the evaluation of the...
6.
van der Weijden C, van der Hoorn A, Potze J, Renken R, Borra R, Dierckx R, et al.
J Cereb Blood Flow Metab
. 2022 Jun;
42(11):2095-2106.
PMID: 35754351
Neuronal damage is the primary cause of long-term disability of multiple sclerosis (MS) patients. Assessment of axonal integrity from diffusion MRI parameters might enable better disease characterisation. 16 diffusion derived...
7.
van der Feen F, de Haan G, van der Lijn I, Fuermaier A, Heersema T, Meilof J, et al.
J Patient Rep Outcomes
. 2022 Apr;
6(1):36.
PMID: 35397039
Background: Visual complaints among people with multiple sclerosis (pwMS) are common, but often difficult to recognize. The Screening Visual Complaints questionnaire (SVCq) has been developed to screen for visual complaints...
8.
van der Weijden C, Meilof J, van der Hoorn A, Zhu J, Wu C, Wang Y, et al.
Eur J Nucl Med Mol Imaging
. 2022 Apr;
49(10):3492-3507.
PMID: 35366079
Purpose: Multiple sclerosis (MS) is a disease characterized by inflammatory demyelinated lesions. New treatment strategies are being developed to stimulate myelin repair. Quantitative myelin imaging could facilitate these developments. This...
9.
van der Weijden C, Pitombeira M, Haveman Y, Sanchez-Catasus C, Campanholo K, Kolinger G, et al.
Insights Imaging
. 2022 Mar;
13(1):63.
PMID: 35347460
Background: Graph theoretical network analysis with structural magnetic resonance imaging (MRI) of multiple sclerosis (MS) patients can be used to assess subtle changes in brain networks. However, the presence of...
10.
van der Weijden C, Garcia D, Borra R, Thurner P, Meilof J, van Laar P, et al.
Neuroimage
. 2020 Nov;
226:117561.
PMID: 33189927
Objectives: Currently, multiple sclerosis is treated with anti-inflammatory therapies, but these treatments lack efficacy in progressive disease. New treatment strategies aim to repair myelin damage and efficacy evaluation of such...